Together, these data support the notion that inappropriate O-GlcNAcylation of specific, key OGT-1 targets leads to this immunodeficiency as the presence or absence of the PTM can dramatically affect protein properties including localization and activity (see Zachara et al. and references therein [3]). The gene discussed is OGT; the disease is immune system disorder.